Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory Support

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump for Treating Cardiogenic Shock

(2017) Dagmar M. Ouweneel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction

(2017) Dagmar M. Ouweneel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Meta-Analysis of Usefulness of Percutaneous Left Ventricular Assist Devices for High-Risk Percutaneous Coronary Interventions

(2016) Alexandros Briasoulis et al.   AMERICAN JOURNAL OF CARDIOLOGY

Incidence of Hemolysis in Patients with Cardiogenic Shock Treated with Impella Percutaneous Left Ventricular Assist Device

(2016) Amit P. Badiye et al.   ASAIO JOURNAL

Decade-Long Trends (2001–2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction

(2016) Robert J. Goldberg et al.  

Decade-Long Trends (2001–2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction

(2016) Robert J. Goldberg et al.   Circulation-Cardiovascular Quality and Outcomes

Temporary Percutaneous Mechanical Circulatory Support in Advanced Heart Failure

(2016) Jessica L. Brown et al.   Heart Failure Clinics

Effectiveness of Protocol Guided Heparin Anticoagulation in Patients with the TandemHeart Percutaneous Ventricular Assist Device

(2015) Yeunju Lee et al.   ASAIO JOURNAL

Developing an Anti-Xa-Based Anticoagulation Protocol for Patients with Percutaneous Ventricular Assist Devices

(2015) Adam Sieg et al.   ASAIO JOURNAL

2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American heart assocation, the cardiological society of India, and sociedad latino America

(2015) Charanjit S. Rihal et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group

(2015) Francesco Burzotta et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Hemodynamic Support with Percutaneous Devices in Patients with Heart Failure

(2015) Navin K. Kapur et al.   Heart Failure Clinics

Effective Anticoagulation for a Percutaneous Ventricular Assist Device Using a Heparin-Based Purge Solution

(2014) Douglas L. Jennings et al.   ANNALS OF PHARMACOTHERAPY

Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients

(2014) Colleen K. McIlvennan et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Discordant aPTT and Anti-Xa Values and Outcomes in Hospitalized Patients Treated with Intravenous Unfractionated Heparin

(2013) Elizabeth A Price et al.   ANNALS OF PHARMACOTHERAPY

Mechanical circulatory support in cardiogenic shock

(2013) K. Werdan et al.   EUROPEAN HEART JOURNAL

The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry

(2013) WILLIAM W. O'NEILL et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

2013 ACCF/AHA Guideline for the Management of Heart Failure

(2013) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: The Mayo Clinic experience

(2012) Oluseun O. Alli et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention

(2012) William W. O'Neill et al.   CIRCULATION

Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock

(2012) Alexander Lauten et al.   Circulation-Heart Failure

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

(2012) Holger Thiele et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin

(2012) Jeremy W. Vandiver et al.   PHARMACOTHERAPY

Is heparin needed for patients with an intra-aortic balloon pump?

(2012) P. H. Pucher et al.   Interactive Cardiovascular and Thoracic Surgery

Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion

(2011) David J Guervil et al.   ANNALS OF PHARMACOTHERAPY

The Percutaneous Ventricular Assist Device in Severe Refractory Cardiogenic Shock

(2010) Biswajit Kar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Techniques and Complications of TandemHeart Ventricular Assist Device Insertion During Cardiac Procedures

(2009) Igor D. Gregoric et al.   ASAIO JOURNAL

A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction

(2008) Melchior Seyfarth et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY